FDA Clearance Tracker · P010059-S004
EYEJET INJECTOR
Last checked: Nov 20, 2026Latest source record: May 23, 2013 (this decision)Source: openFDAMethods & limitations
Decided
May 23, 2013
Approved
Time to decision
562 days
Received Nov 8, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010059-S004
- Device name
- EYEJET INJECTOR
- Applicant
- Morcher GmbH
- Applicant location
- Stuttgart
- Received
- Nov 8, 2011
- Decided
- May 23, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010059
Device type
- Device type
- Ring, endocapsular (MRJ)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE EXPANSION OF YOUR FAMILY OF CAPSULAR TENSION RINGS (CTRS) AVAILABLE PRE-LOADED ON THE EYEJET INJECTOR TO INCLUDE NEW CTR MODELS TYPE 10G, 10L, 15, 15A, AND 15B. IN ADDITION, YOU REQUESTED APPROVAL TO SUPPLY CURRENTLY APPROVED CTR TYPE 10C AS PRE-LOADED ON THE EYEJET INJECTOR.
Source documents
Other decisions for Morcher GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.